XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Stock-Based Compensation  
Schedule of stock option activity under all of the Company's equity incentive plans

Weighted

Weighted

 Average 

Shares 

Number of 

 Average 

Remaining 

Aggregate

 Available for 

Shares 

Exercise 

Contractual 

 Intrinsic 

    

Grant

    

Outstanding

    

Price

    

Life (Years)

    

 Value(000’s)

Available and outstanding as of December 31, 2022

3,538,268

10,081,915

$

3.11

7.61

$

4,099

2022 Equity incentive plan increase

1,917,456

Granted

(20,000)

20,000

1.67

Exercised

(213,020)

1.05

Forfeited

835,212

(835,212)

5.03

Available and outstanding as of March 31, 2023

6,270,936

9,053,683

$

2.98

7.27

$

333

Vested and exercisable as of March 31, 2023

5,405,758

$

2.15

6.36

$

333

Schedule of assumptions utilized for option grants

    

Three months ended

    

March 31,

2023

    

2022

Risk-free interest rate

3.76

%

0.96

%

Expected dividend yield

%

%

Expected volatility

54.09

%

53.84

%

Expected term (in years)

5.99

6.08

Schedule of stock-based compensation expense recognized in the Company's condensed consolidated statements of operations

    

Three months ended

March 31, 

2023

    

2022

Cost of services

$

93

$

80

Research and development

227

Sales and marketing

53

71

General and Administrative

300

347

Total

$

446

$

725